PC

Padma Chinthapally

Active Director Director DIN 11030440
DIN 11030440 First appointment Mar 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Padma Chinthapally

Data last updated:

Padma Chinthapally is a Director at Neptus Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11030440
Primary Designation Director
Industry Pharma
First Appointment 31 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Mar 20252025Active

Board colleagues of Padma Chinthapally

NameDINCompanyDesignation
Sriramula Sravanthi11030439Neptus Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Neptus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Padma Chinthapally

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Padma Chinthapally

Padma Chinthapally currently holds 1 directorship: Neptus Pharmaceuticals Private Limited (Director, since 31 Mar 2025).

Padma Chinthapally was first appointed on 31 Mar 2025 as Director at Neptus Pharmaceuticals Private Limited.

The current boards of Padma Chinthapally's companies include Sriramula Sravanthi (Neptus Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available